HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination treatment with plasmapheresis and sirolimus does not seem to benefit nephrogenic systemic fibrosis.

AuthorsG Tsagalis, E Psimenou, A Laggouranis
JournalThe International journal of artificial organs (Int J Artif Organs) Vol. 31 Issue 10 Pg. 913-4 (Oct 2008) ISSN: 0391-3988 [Print] United States
PMID19009511 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Bacterial Agents
  • Sirolimus
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Brain (pathology)
  • Combined Modality Therapy
  • Disease Progression
  • Fatal Outcome
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Nephrogenic Fibrosing Dermopathy (drug therapy, therapy)
  • Plasmapheresis
  • Polycystic Kidney, Autosomal Dominant (pathology, therapy)
  • Renal Dialysis
  • Sirolimus (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: